SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-029427 from BioSig Technologies, Inc. (BSGM) (CIK 0001530766) (STEX)

BioSig Technologies, Inc. (BSGM) (CIK 0001530766)
Date: July 29, 2024 · CIK: 0001530766 · Accession: 0001493152-24-029427

AI Filing Summary & Sentiment

File numbers found in text: 333-280525

Date
July 29, 2024
Author
Chief
Form
CORRESP
Company
BioSig Technologies, Inc. (BSGM) (CIK 0001530766)

Letter

July 29, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

F. Street, N.E.

Washington, D.C. 20549

Attention: Aja Eiden and Katherine Bagley

Re: BioSig Technologies, Inc.

Registration Statement on Form S-1

File No. 333-280525

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on Wednesday, July 31, 2024, or as soon thereafter as practicable.

If you have any questions, please call Avital Perlman, Esq. at (212)-930-9700 or Christian Lichtenberger, Esq. at (646)-810-0591.

Very
truly yours,
BIOSIG
TECHNOLOGIES, INC.

Show Raw Text
CORRESP
1
filename1.htm

July
29, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Industrial Applications and Services

100
F. Street, N.E.

Washington,
D.C. 20549

Attention:
Aja Eiden and Katherine Bagley

Re:
BioSig Technologies, Inc.

Registration
Statement on Form S-1

File
No. 333-280525

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date
for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on
Wednesday, July 31, 2024, or as soon thereafter as practicable.

If
you have any questions, please call Avital Perlman, Esq. at (212)-930-9700 or Christian Lichtenberger, Esq. at (646)-810-0591.

    Very
    truly yours,

    BIOSIG
    TECHNOLOGIES, INC.

    By:
    /s/
    Anthony Amato

    Name:
    Anthony
    Amato

    Title:
    Chief
    Executive Officer